P&G’s Q1 FY 2025: Restructuring hits hard, but core EPS still climbs—What’s next?
Procter & Gamble (P&G) reported a mixed performance for Q1 FY 2025, with net sales decreasing by 1% to $21.7 billion, while organic sales grew ... Read More
Procter & Gamble recalls certain Zevo insect killer value packs in US
Procter & Gamble has issued a voluntary recall of one stock-keeping unit (SKU) of Zevo Fly, Gnat and Fruit Fly Flying Insect Killer Value Packs ... Read More
Procter & Gamble completes game-changing acquisition of Merck’s consumer health unit
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion acquisition of German pharmaceutical giant Merck’s consumer ... Read More
Procter & Gamble to acquire Merck’s consumer health business for €3.4bn
Procter & Gamble (P&G), a leading US consumer goods company, has finalized a deal to acquire the consumer health business of German pharmaceutical company Merck ... Read More